Assurex Health sold for $225M

August 3, 2016

Assurex Health a fast-growing Mason firm whose genetic tests help doctors determine the best medications to treat patients with mental health disorders, has been sold for $225 million.

The deal with Utah-based Myraid Genetics (NASDAQ: MYGYN) could be worth up to $410 million if Assurex Health meets undisclosed performance-based milestones worth $185 million. Read More


Comments are closed.